<p class="MsoNormal">To receive news directly from eLife, feel free to sign up at <a href="http://www.elifesciences.org/crm/civicrm/profile/create?reset=1&gid=11">http://www.elifesciences.org/crm/civicrm/profile/create?reset=1&gid=11</a>. </p>
<p class="MsoNormal"><br></p><p class="MsoNormal">P.S. on the following: Mark Patterson (eLife Managing Executive Editor), Ian Mulvany (our head of technology), and I will also be on hand. We look forward to having you!</p>
<p class="MsoNormal"><br></p><p class="MsoNormal">-------------------------------</p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><b><span lang="EN-US">eLife
is holding an online Open House to share news on the development of its
anticipated open-access journal for the very best in life science and
biomedical research. Join us.</span></b></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">eLife is the new researcher-driven
initiative to reshape science communication launched in collaboration by three
prestigious biomedical research funders: the Howard Hughes Medical Institute
(USA), Max Planck Society (Germany), and the Wellcome Trust (UK). Announced in
June 2011, the first aim of the initiative is to launch an open-access journal
for the most important advances in the life sciences and biomedicine. The <i>eLife </i>journal will showcase papers
identified through a new rapid, fair, and constructive review process, and
serve as a platform for innovation in the presentation and use of research
content. </span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">While eLife presses toward launch of the
journal by the end of 2012, interest in how this unique funder-researcher
collaboration could change science and scientific publishing grows. Media
coverage has been extensive and has included detailed stories on one of <i>eLife</i>s first accepted papers just
weeks after we opened for submissions.</span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">On September 12, please join us for an online
Open House to learn more about what the initiative aims to do, the scope of the
journal, how the review process is different, the papers that have been
accepted, the status of launch, and more. eLife Editor-in-chief Randy Schekman
P</span><span style="background:white">rofessor of
Molecular and Cell Biology at the University of California (Berkeley), and an
Investigator at the Howard Hughes Medical Institute will host. Scientists, students,
potential reviewers, members of the eLife community, librarians, research
funders, publishers, open-access advocates all are welcome.</span><span lang="EN-US"></span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">The eLife online Open House will be held:</span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">Wednesday, September 12, 2012 </span></p>
<p class="MsoNormal"><span lang="EN-US">9:00 10:00AM U.S. Pacific time </span></p>
<p class="MsoNormal"><span lang="EN-US">(12:00 1:00PM U.S. Eastern | 5:00
6:00PM UK)</span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">To determine the time in another world
region, visit <a href="http://www.worldtimeserver.com/convert_time_in_US-CA.aspx?y=2012&mo=9&d=12&h=9&mn=0">http://www.worldtimeserver.com/convert_time_in_US-CA.aspx?y=2012&mo=9&d=12&h=9&mn=0</a></span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">Please register to attend by September 10
at <a href="http://www.elifesciences.org/crm/civicrm/event/info?id=7&reset=1">http://www.elifesciences.org/crm/civicrm/event/info?id=7&reset=1</a>.
(Phone and Web access will be required to participate).</span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">To share your questions in advance, post to
the eLife Web site (<a href="http://www.elifesciences.org/open-house">http://www.elifesciences.org/open-house</a>),
Tweet #eLifeopen, or email <a href="mailto:d.clarke@elifesciences.org">d.clarke@elifesciences.org</a>.</span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">To learn more about eLife and the growing
momentum behind the initiative, visit <a href="http://elifesciences.org">elifesciences.org</a>. </span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><span lang="EN-US">###</span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<p class="MsoNormal"><b><span lang="EN-US">About
eLife </span></b></p>
<p class="MsoNormal"><span lang="EN-US">eLife is a unique collaboration between the
funders and practitioners of research to communicate ground-breaking
discoveries in the life and biomedical sciences in the most effective way. Set
for launch in late 2012, the <i>eLife</i>
journal will be a platform for maximising
the reach and influence of new discoveries and to showcase new approaches to the
presentation, use, and assessment of research. As an open-access journal, <i>eLife </i>will deliver access to content for
free, online, immediately on publication, and will encourage maximum possible
reach and utility of the content by publishing under the terms of the Creative
Commons Attribution License, which is emerging as the gold standard for
open-access publishing. Learn more at <a href="http://elifesciences.org">elifesciences.org</a>.</span></p>
<p class="MsoNormal"><span lang="EN-US"> </span></p>
<div><br></div>-- <br>
<p>------------------------------</p><p><img src="http://www.elifesciences.org/wp-content/uploads/2012/08/elife_128.png"><br></p>
<p>Jennifer McLennan<br>Communications, eLife</p>
<p>+1-301-215-8938<br>+1-202-631-8854 (c)</p>
<p><a href="http://elifesciences.org/" target="_blank">http://elifesciences.org</a></p>
<p>eLife Sciences Publications, Ltd is a limited liability non-profit non-stock corporation incorporated in the State of Delaware, USA, with company number 5030732, and is registered in the UK with company number FC030576 and branch number BR015634 at the address Suite 203, Sheraton House, Castle Park, Cambridge CB3 0AX.</p>
<br>